New Jersey Headlines

Grand View Research, Inc. – Market Research And Consulting.

According to a report, “Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report By Product (Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols, Carbohydrates), By Region, And Segment Forecasts, 2019 – 2025”, published by Grand View Research, Inc., the global biopharmaceutical excipients market size is expected to reach USD 2.7 billion by 2025. It is anticipated to expand at a CAGR of 6.08% over the forecast period. Rapid expansion of the biopharmaceutical industry due to increasing manufacturing capacities is one of the key driving force of this market. Rise in the number of protein therapeutics coupled with the presence of a substantial number of excipients to protect these proteins from degradation is also driving the market growth.

Key Takeaways from the report:

• Easy availability and wide usage of dextrose, sucrose, and starch in biopharmaceutical formulations has resulted in the largest revenue share of carbohydrates

• Polyols is expected to be the fastest-growing product segment in the global biopharmaceutical excipients market

• This can be attributed to increasing concerns regarding protein degradation, which can be reduced by using polyols

• North America led the global market in 2017 accounting for the largest revenue share as a result of the presence of key biopharmaceutical manufacturers in U.S.

• Emerging markets, such as India and China, are projected to be driven by the contract manufacturers operating in these regions

• Some major biopharmaceutical excipient suppliers are Merck KGaA; Roquette; Clariant; DFE Pharma; SPI Pharma, Inc.; and JRS Pharma LP

• Most of these companies are engaged in establishing partnerships with biopharmaceutical manufacturers to understand their needs and develop raw materials specific to the process and end-product

Browse More Reports in Pharmaceuticals Industry:

• Cervical Cancer Treatment Market: Increased treatment penetration and rising disease incidence are projected to drive the Cervical Cancer Treatment market growth over the next few years. Although, sexually transmitted HPV is a major cause, the disease can also be triggered by other factors, such as oral contraceptives, multiple sexual partners, smoking, and HIV infection. 

• Antibiotic Resistance Market: Rising burden of antibiotic-resistant infections and emergence of multi-drug resistant pathogens has been driving the Antibiotic Resistance market.

Investigational studies that are implemented for the impact analysis of excipient variability on in vitro dissolution testing are expected to reduce the attrition rate of final products and increase the reproducibility. These studies help scientists in gaining insights on the in vivo functioning and pharmacodynamic analysis of large molecules. The market exhibits continuous need of innovative excipient technologies to prolong the in vivo effectiveness of biologics and for improvement in the product delivery. Moreover, extensive R&D for the development of raw materials that help improve yields in mammalian cell-culture processes is expected to drive the market in future.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: Switzerland
Website: www.grandviewresearch.com/industry-analysis/biopharmaceutical-excipients-market